levodopa/carbidopa/entacapone

DRUG2 trials

Sponsors

Novartis, Second Affiliated Hospital of Soochow University

Conditions

Parkinson DiseaseParkinson's Disease

Phase 4

Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off

CompletedNCT00391898

NovartisParkinson's Disease

Start: 2006-10-31End: 2008-06-30Updated: 2011-03-15

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

Second Affiliated Hospital of Soochow UniversityParkinson Disease

Start: 2023-11-15End: 2024-12-31Target: 60Updated: 2024-02-01